Gelucire 50-13

Known as: G 50-13 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-2017
0119912017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (IBP) are among the most prescribed drugs across the globe… (More)
Is this relevant?
2017
2017
The present studies were undertaken to develop solvent-free solid dispersions (SDs) for poorly soluble anti-inflammatory drugs… (More)
Is this relevant?
2015
2015
The aim of the study was to investigate the effect of novel polymer/lipid formulations on the dissolution rates of the water… (More)
  • table I
  • figure 1
  • figure 2
  • figure 3
  • table II
Is this relevant?
2012
2012
Gelucire 50/13 (G50/13) was assessed to develop controlled release formulation of salbutamol sulphate (SBL) a highly water… (More)
  • table 1
  • table 2
  • table 3
  • figure 2
  • figure 1
Is this relevant?
2009
2009
The aim of this study was to prepare and characterize solid dispersions of water insoluble non-steroidal anti-inflammatory drug… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2003
2003
The aim of the present study was to prepare matrix pellets loaded nifedipine (NF) as model drug by pellitization technique by… (More)
  • table 1
  • table 4
  • table 5
  • table 3
  • table 6
Is this relevant?
1991
1991
Release of D&C Yellow No. 10 and anhydrous theophylline have been determined from a thermosoftening, hydrophilic matrix, Gelucire… (More)
Is this relevant?